Deborah Yurgelun-Todd, PhD, professor of psychiatry and director of the Cognitive Neuroimaging Laboratory at The Brain Institute at the University of Utah, Salt Lake City, describes her present research and the research she has conducted on brain supporting nutraceuticals such as citicoline. She also describes the importance of emphasizing risk reduction research and discovering ways to improve late life outcomes specific to brain function.

Approximate listening time: 11 minutes.

About the Expert

Deborah Yurgelun-Todd, PhD, is a professor of psychiatry and the director of the Cognitive Neuroimaging Laboratory at The Brain Institute at the University of Utah, Salt Lake City. She held a similar position at McLean Hospital, Harvard Medical School, Belmont, Massachusetts, for 12 years before joining the Utah Medical School. Yurgelun-Todd is a recognized expert on the application of neuroimaging methods to assess neurophysiological and neuropsychological changes associated with normal development and neuropsychiatric disorders.

Deborah Yurgelun-Todd, PhD, professor of psychiatry and director of the Cognitive Neuroimaging Laboratory at The Brain Institute at the University of Utah, Salt Lake City, describes her present research and the research she has conducted on brain supporting nutraceuticals such as citicoline. She also describes the importance of emphasizing risk reduction research and discovering ways to improve late life outcomes specific to brain function.

Approximate listening time: 11 minutes.

About the Expert

Deborah Yurgelun-Todd, PhD, is a professor of psychiatry and the director of the Cognitive Neuroimaging Laboratory at The Brain Institute at the University of Utah, Salt Lake City. She held a similar position at McLean Hospital, Harvard Medical School, Belmont, Massachusetts, for 12 years before joining the Utah Medical School. Yurgelun-Todd is a recognized expert on the application of neuroimaging methods to assess neurophysiological and neuropsychological changes associated with normal development and neuropsychiatric disorders.